IGMS Stock Price | IGM Biosciences Inc P/E, Revenue, EPS, & Forecasts

IGM Biosciences Inc • IGMS

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About IGM Biosciences Inc

Ticker

IGMS

Trading on

NASDAQ

ISIN

US4495851085

Industry

Biotechnology

Sector

Healthcare

CEO

Mary Beth Harler M.D.

Headquarters

325 East Middlefield Road, Mountain View, CA, United States, 94043

Employees

Website

https://igmbio.com

IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer and autoimmune and inflammatory diseases. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California. As of August 14, 2025, IGM Biosciences, Inc. operates as a subsidiary of Concentra Biosciences, LLC.

Metrics

BasicAdvanced

Market cap

$76.6M

P/E ratio

EPS

-$0.90

Dividend Yield

0.00%

Beta

0.59

Forward P/E ratio

EBIDTA

$17.6M

Ex dividend date

Price & volume

Market cap

$76.6M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

0.53

Price to book

0.76

Earnings

EPS

-$0.90

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$17.6M

Revenues (TTM)

$145M

Revenues per share (TTM)

$2.38

Technicals

Beta

0.59

52-week High

$11.62

52-week Low

$0.92

50-day moving average

$1.27

200-day moving average

$2.89

Short ratio

0.38

Short %

2.11%

Management effectiveness

ROE (TTM)

-47.82%

ROA (TTM)

2.89%

Profit margin

-36.81%

Gross profit margin

$-5.5M

Operating margin

90.72%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

11,353.20%

Share stats

Outstanding Shares

36.6M

Float

2.14B

Insiders %

35.39%

Institutions %

46.88%

Analyst Insights & forecasts

0% Buy

80% Hold

20% Sell

Based on information from 5 analysts.

Average price target

$1.12

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$1.01

-$0.80

-26.25%

Q3 • 24Missed

-$0.61

-$0.71

14.16%

Q4 • 24Beat

-$0.86

-$0.45

-91.11%

Q1 • 25Missed

$1.58

-$0.12

1,416.67%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0.5M

$-52.9M

-10,599.60%

Q1 • 25

$144M

$97.6M

67.94%

Q2 • 25

28,682.16%

-284.50%

-100.64%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$207M

$206M

99.66%

Q1 • 25

$107M

$6.1M

5.66%

Q2 • 25

-48.29%

-97.06%

-94.32%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-32.5M

$42.7M

$0M

$-32.6M

Q1 • 25

$-50.8M

$44.5M

$0M

$-50.8M

Q2 • 25

56.18%

4.23%

140.00%

56.04%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a IGM Biosciences Inc share?

IGM Biosciences Inc shares are currently traded for undefined per share.

How many shares does IGM Biosciences Inc have?

IGM Biosciences Inc currently has 36.6M shares.

Does IGM Biosciences Inc pay dividends?

No, IGM Biosciences Inc doesn't pay dividends.

What is IGM Biosciences Inc 52 week high?

IGM Biosciences Inc 52 week high is $11.62.

What is IGM Biosciences Inc 52 week low?

IGM Biosciences Inc 52 week low is $0.92.

What is the 200-day moving average of IGM Biosciences Inc?

IGM Biosciences Inc 200-day moving average is $2.89.

Who is IGM Biosciences Inc CEO?

The CEO of IGM Biosciences Inc is Mary Beth Harler M.D..

How many employees IGM Biosciences Inc has?

IGM Biosciences Inc has 16 employees.

What is the market cap of IGM Biosciences Inc?

The market cap of IGM Biosciences Inc is $76.6M.

What is the P/E of IGM Biosciences Inc?

The current P/E of IGM Biosciences Inc is null.

What is the EPS of IGM Biosciences Inc?

The EPS of IGM Biosciences Inc is -$0.90.

What is the PEG Ratio of IGM Biosciences Inc?

The PEG Ratio of IGM Biosciences Inc is null.

What do analysts say about IGM Biosciences Inc?

According to the analysts IGM Biosciences Inc is considered a hold.